Detalhe da pesquisa
1.
Point-of-Care Ultrasound training in undergraduate education in the European Union: current situation and perspectives.
Ultrasound J
; 16(1): 9, 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38349580
2.
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers.
Clin Infect Dis
; 52(4): 522-31, 2011 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21208909
3.
Booster vaccination after neonatal priming with acellular pertussis vaccine.
J Pediatr
; 156(4): 675-8, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20303444
4.
Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.
BMC Infect Dis
; 10: 297, 2010 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20950456
5.
The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule.
BMC Infect Dis
; 10: 298, 2010 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20950457
6.
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months.
Pediatr Infect Dis J
; 26(1): 1-7, 2007 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17195697
7.
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States.
Am J Trop Med Hyg
; 96(6): 1325-1337, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28719287
8.
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Pediatr Infect Dis J
; 25(8): 713-20, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16874171
9.
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.
Curr Opin Virol
; 17: 57-65, 2016 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26827165
10.
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.
Medicine (Baltimore)
; 95(6): e2673, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26871794
11.
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
PLoS One
; 10(5): e0125954, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25961283
12.
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
Vaccine
; 32(22): 2657-65, 2014 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-24144472
13.
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients.
J Immunol Methods
; 414: 1-10, 2014 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25224748
14.
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
Pediatrics
; 118(3): e602-9, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16950952